from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2181/-

LFCtreatmentdescriptionclass of inhibitor

-1.312

Amikacinug/mL Amikacintranslation

-1.508

Cap5-10ug/mL Capreomycintranslation

-1.649

Rox10-50 ug/mL Roxithromycintranslation

0.032

SM2-5 ug/mL Streptomycintranslation

-1.630

Tet5-10 ug/mL Tetracyclinetranslation

-0.519

Rif0.2-5ug/mL Rifampicintranscription

-0.863

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.338

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.931

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.594

CPZ10-50 ug/mL Chlorpromazinerespiration

1.265

Clofazimine10-13 ug/mL Clofaziminerespiration

0.021

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.692

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.386

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.465

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.569

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.028

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.717

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.649

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.113

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.676

KCN5-20 ug/mL Potassium cyaniderespiration

0.580

NaN30.2-2 mM Sodium aziderespiration

-0.317

Nigericin50 uM Nigericinrespiration

0.959

TRC10-150 ug/mL Triclosanrespiration

0.260

TRZ10-25 ug/mL Thioridazinerespiration

-0.689

Valinomycin0.5-10 uM Valinomycinrespiration

0.719

ZnSO42 mM ZnSO4respiration

-0.213

menadione6-10 ug/mL Menadionerespiration

0.481

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.089

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.408

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.013

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.734

NRP_1Non-replicating persistence stage 1dosRassociated

0.131

Amp0.2mg/mL AmpicillincellWall

-0.146

Cephalexin20-100 ug/mL CephalexincellWall

0.323

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.457

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.150

EMB10-20 ug/mL EthambutolcellWall

0.596

Eta12-40 ug/mL EthionamidecellWall

0.697

INH0.2-0.4 ug/mL IsoniazidcellWall

0.384

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.185

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.212

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.018

BZA0.12 mg/mL BenzamidearomaticAmides

-0.354

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.370

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.603

H2O24 mM hydrogen peroxideDNAdamaging

-0.082

Levo10 ug/mL LevofloxacinDNAdamaging

-0.482

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.741

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.036

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.400

UVUV-irradiationDNAdamaging

0.124

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.630

Antimycin12.5-50 ug/mL Antimycin A?

-0.077

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.612

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.662

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.546

PA8240.2-2 ug/mL PA-824?

1.581

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.201

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.104

Verapamil50 uM Verapamil?

-0.306

mercaptoethanol2 mM 2-Mercaptoethanol?

0.089

methoxatin10-20 ug/mL Methoxatin?